501. Bax J J , Abraham T, Barold SS, et al . Cardiac resynchronization therapy: Part 1--issues before device implantation. J Am Coll Cardiol 2005; 46: 2153-
2167.
502. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic
patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008; 52: 1834-1843.
503. Mos s AJ , Hal l WJ , Cannom DS, et al . Cardiacresynchronization therapy for the prevention of heart-failure events. N Eng J Med 2009; 361: 1329-
1338.
504. Cleland JG, Freemantle N, Daubert JC, et al. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report
from the CARE-HF study. Heart (British Cardiac Society) 2008; 94: 278-283.
505. Curtis AB, Adamson PB, Chung E, et al. Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and
rationale. Journal of cardiovascular electrophysiology 2007; 18: 965-971.
506. Belardinelli R, Georgiou D, Cianci G, et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on
functional capacity, quality of life, and clinical outcome. Circulation 1999; 99: 1173-1182.
507. Stolen KQ, Kemppainen J, Ukkonen H, et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with
dilated cardiomyopathy. J Am Coll Cardiol 2003; 41: 460-467.
508. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation,
and autonomic function. Circulation 1992; 85: 2119-2131.
509. Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation,
and prevention. Circulation 2003; 107: 1210-1225.
510. Jette M, Heller R, Landry F, et al. Randomized 4-week exercise program in patients with impaired left ventricular function. Circulation 1991; 84: 1561-
1567.
511. Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll
Cardiol 1993; 21: 1101-1106.
512. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and
ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995; 25: 1239-1249.
513. Belardinelli R, Georgiou D, Scocco V, et al. Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol 1995; 26: 975-982.
514. Belardinelli R, Georgiou D, Cianci G, et al. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and
prognostic implications. Circulation 1995; 91: 2775-2784.
515. Kavanagh T, Myers MG, Baigrie RS, et al. Quality of life and cardiorespiratory function in chronic heart failure: effects of 12 months’ aerobic training.
Heart (British Cardiac Society) 1996; 76: 42-49.
516. Demopoulos L, Bijou R, Fergus I, et al. Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity while
minimizing the increase in ventricular wall stress. J Am Coll Cardiol 1997; 29: 597-603.
517. 安村良男，泰志 高洋原．β遮断薬服用中の慢性心不全患者に対する低レベル運動療法の試み．心臓リハビリテーション学会誌 1998.
518. Demopoulos L, Yeh M, Gentilucci M, et al. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in
patients with congestive heart failure. Circulation 1997; 95: 1764-1767.
519. Fitchet A, Doherty PJ, Bundy C, et al. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised
controlled trial. Heart (British Cardiac Society) 2003; 89: 155-160.
520. Kamke W, Dovifat C, Schranz M, et al. Cardiac rehabilitation in patients with implantable defibrillators. Feasibility and complications. Zeitschrift fur
Kardiologie 2003; 92: 869-875.
521. Belardinelli R, Capestro F, Misiani A, et al. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent
vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev
Rehabil 2006; 13: 818-825.
522. Kruse M, Hochstrasser S, Zwisler AD, et al. Comprehensive cardiac rehabilitation: a cost assessment based on a randomized clinical trial. International
journal of technology assessment in health care 2006; 22: 478-483.
523. Haykowsky MJ, Liang Y, Pechter D, et al. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the
benefit depends on the type of training performed. J Am Coll Cardiol 2007; 49: 2329-2336.
524. Giannuzzi P, Temporelli PL, Corra U, et al. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of
the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVDCHF) Trial. Circulation 2003; 108: 554-559.
525. Myers J, Wagner D, Schertler T, et al. Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy:
application of magnetic resonance myocardial tagging. Am Heart J 2002; 144: 719-725.
526. Passino C, Severino S, Poletti R, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart
failure. J Am Coll Cardiol 2006; 47: 1835-1839.
527. Maria Sarullo F, Gristina T, Brusca I, et al. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide
levels in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 812-817.
528. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National
Heart, Lung, and Blood Institute. Clinical practice guideline 1995: 1-23.
529. Linxue L, Nohara R, Makita S, et al. Effect of long-term exercise training on regional myocardial perfusion changes in patients with coronary artery
disease. Jpn Circ J 1999; 63: 73-78.
530. Belardinelli R, Georgiou D, Ginzton L, et al. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of
dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 1998; 97: 553-561.
531. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Eng J Med 2000; 342:
454-460.
532. Ohtsubo M, Yonezawa K, Nishijima H, et al. Metabolic abnormality of calf skeletal muscle is improved by localised muscle training without changes in blood
flow in chronic heart failure. Heart (British Cardiac Society) 1997; 78: 437-443.
533. Mancini DM, Henson D, La Manca J, et al. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart
failure. Circulation. 1995; 91: 320-329.
534. Chua TP, Anker SD, Harrington D, et al. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. British
heart journal 1995; 74: 381-385.
535. Kobayashi N, Tsuruya Y, Iwasawa T, et al. Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained
extremities. Circ J 2003; 67: 505-510.
536. Hambrecht R, Adams V, Erbs S, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing
phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: 3152-3158.
537. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol
2005; 45: 1563-1569.
538. Adamopoulos S, Parissis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in
patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 653-663.
539. Oya M, Itoh H, Kato K, et al. Effects of exercise training on the recovery of the autonomic nervous system and exercise capacity after acute myocardial
infarction. Japanese Circulation journal 1999; 63: 843-848.
540. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, et al. Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart
failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 67-73.
541. Adamopoulos S, Ponikowski P, Cerquetani E, et al. Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training.
Eur Heart J 1995; 16: 1380-1386.
542. Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. The American
journal of medicine 2004; 116: 693-706.
543. O’Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized
controlled trial. JAMA 2009; 301: 1439-1450.
544. Tei C. Waon therapy: soothing warmth therapy. J Cardiol 2007; 49: 301-304.
545. Tei C, Tanaka N. Thermal vasodilation as a treatment of congestive heart failure: a novel approach. J Cardiol 1996; 27: 29-30.
546. Basford JR, Oh JK, Allison TG, et al. Safety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: a pilot report.
Archives of physical medicine and rehabilitation 2009; 90: 173-177.
547. Kihara T, Biro S, Imamura M, et al. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure.
J Am Coll Cardiol 2002; 39: 754-759.
548. Kihara T, Biro S, Ikeda Y, et al. Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J 2004; 68:
1146-1151.
549. Kihara T, Miyata M, Fukudome T, et al. Waon therapy improves the prognosis of patients with chronic heart failure. J Cardiol 2009; 53: 214-218.
550. Ikeda Y, Biro S, Kamogawa Y, et al. Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in
cardiomyopathic hamsters. Circ J 2005; 69: 722-729.
551. 北村惣一郎，篤 天，真弘 遠，他．循環器病の診断と治療に関するガイドライン（2004－ 2005年度合同研究班報告）虚血性心疾患に対するバイパスグラフトと手
術術式の選択ガイドライン．Circ J 2006; 70 (Suppl. IV): 1477-1553.
552. Di Mauro M, Di Giammarco G, Vitolla G, et al. Impact of no-to-moderate mitral regurgitation on late results after isolated coronary artery bypass
grafting in patients with ischemic cardiomyopathy. The Annals of thoracic surgery 2006; 81: 2128-2134.
553. Filsoufi F, Rahmanian PB, Castillo JG, et al. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with
severely depressed left ventricular function. The Annals of thoracic surgery 2007; 84: 808-816.
554. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular
dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998; 116: 50-59.
555. Suma H, Isomura T, Horii T, et al. Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. The Annals of thoracic
surgery 2006; 82: 1344-1348.
556. Menicanti L, Castelvecchio S, Ranucci M, et al. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular
restoration. J Thorac Cardiovasc Surg 2007; 134: 433-441.
557. Matsui Y, Fukada Y, Suto Y, et al. Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg 2002; 124: 395-397.
558. Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Eng J Med 2009; 360:
1705-1717.
559. Buckberg GD. Questions and answers about the STICH trial a different perspective. J Thorac Cardiovasc Surg 2005; 130: 245-249.
560. Batista RJ, Santos JL, Takeshita N, et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. Journal of cardiac
surgery 1996; 11: 96-97; discussion 8.
561. Franco-Cereceda A, McCarthy PM, Blackstone EH, et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to
transplantation? J Thorac Cardiovasc Surg 2001; 121: 879-893.
562. Suma H, Isomura T, Horii T, et al. Nontransplant cardiac surgery for end-stage cardiomyopathy. J Thorac Cardiovasc Surg 2000; 119: 1233-1244.
563. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults:
a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration
with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
564. Suma H, Tanabe H, Uejima T, et al. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy. Eur
J Cardiothorac Surg. 2009; 36: 280-284; discussion 4-5.
565. Bolling SF, Pagani FD, Deeb GM, et al. Intermediate-term Cardiovasc Surg 1998; 115: 381-386; discussion 7-8.
566. Daimon M, Fukuda S, Adams DH, et al. Mitral valve repair with Carpentier-McCarthy-Adams IMR ETlogix annuloplasty ring for ischemic mitral
regurgitation: early echocardiographic results from a multi-center study. Circulation 2006; 114 (1 Suppl.): I588-593.
567. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. The Annals of thoracic surgery 2004; 77:
1989-1997.
568. Borger MA, Murphy PM, Alam A, et al. Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007;
133: 1483-1492.
569. Matsui Y, Fukada Y, Naito Y, et al. Integrated overlapping ventriculoplasty combined with papillary muscle plication for severely dilated heart failure.
J Thorac Cardiovasc Surg 2004; 127: 1221-1223.
570. Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. The Annals of thoracic
surgery 2002; 74: 600-601.
571. Langer F, Schafers HJ. RING plus STRING: papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation. J Thorac
Cardiovasc Surg 2007; 133: 247-249.
572. 松田暉，大北裕，川副浩平，他．循環器病の診断と治療に関するガイドライン（2006年度合同研究班報告）：弁膜疾患の非薬物治療に関するガイドライン
（2007年改訂版）．2007.
573. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for
the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists:
endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-231.
574. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left
ventricular dysfunction. J Am Coll Cardiol 2002; 39: 1356-1363.
575. Taniguchi K, Nakano S, Hirose H, et al. Preoperative left ventricular function: minimal requirement for successful late results of valve replacement for
aortic regurgitation. J Am Coll Cardiol 1987; 10: 510-518.
576. Horskotte D, Schulte HD, Bircks W, et al. The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study. The
Journal of heart valve disease. 1993; 2: 150-158.
577. Bonow RO, Nikas D, Elefteriades JA. Valve replacement for regurgitant lesions of the aortic or mitral valve in advanced left ventricular dysfunction.
Cardiology clinics 1995; 13: 73-83, 5.
578. Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy.
Circulation 1999; 100: 1380-1386.
579. Maisch B, Seferovic PM, Ristic AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on
the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25: 587-610.
580. Ha JW, Oh JK, Schaff HV, et al. Impact of left ventricular function on immediate and long-term outcomes after pericardiectomy in constrictive
pericarditis. J Thorac Cardiovasc Surg 2008; 136: 1136-1141.
581. Schwefer M, Aschenbach R, Heidemann J, et al. Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management. Eur
J Cardiothorac Surg 2009; 36: 502-510.
582. Ueda Y, Osada H, Osugi H. Thoracic and cardiovascular surgery in Japan during 2005. Annual report by the Japanese Association for Thoracic Surgery.
General thoracic and cardiovascular surgery 2007; 55: 377-399.
583. Ueda Y, Fujii Y, Udagawa H. Thoracic and cardiovascular surgery in Japan during 2006: annual report by the Japanese Association for Thoracic Surgery.
General thoracic and cardiovascular surgery 2008; 56: 365-388.
584. 三瀬直文，杉本徳一郎．持続的血液濾過透析．日本臨床2007; 915: 259-262.
585. 馬場彰泰，村山章，若林靖久．拡張型心筋症患者の免疫吸着療法に有効な吸着カラムの同定．日本アフェレシス学会雑誌 2004; 23: 101-102.
586. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced
myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999; 33: 1833-1840.
587. 中谷武嗣．新版経皮的心肺補助法－PCPSの最前線．秀潤社 2004: 141-148.
588. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device
versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588.
589. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk
percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. Jacc 2009; 2: 91-96.
590. Yahagi N, Kumon K, Nakatani T, et al. Inhaled nitric oxide for the management of acute right ventricular failure in patients with a left ventricular assist
system. Artificial organs 1995; 19: 557-578.
591. Takano H, Nakatani T. Ventricular assist systems: experience in Japan with Toyobo pump and Zeon pump. The Annals of thoracic surgery 1996; 61:
317-322.
592. 中谷武嗣．補助人工心臓 日本内科学会雑誌．2005: 111-118.
593. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. The Annals of thoracic
surgery 1992; 53: 1080-1090.
594. Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. The Annals of
thoracic surgery 1994; 57: 51-57; discussion 7-8.
595. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left
ventricular assist system. Annals of surgery 1995; 222: 327-336; discussion 36-38.
596. Hetzer R, Muller J, Weng Y, et al. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. The Annals of thoracic
surgery 1999; 68: 742-749.
597. Copeland JG, Pavie A, Duveau D, et al. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993 to 1995.
J Heart Lung Transplant 1996; 15 (1 Pt 1): 94-99.
598. Dowling RD, Gray LA, Jr., Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004;
127: 131-141.
599. 許俊鋭．本邦におけるDestination Therapyの夜明け．呼吸と循環 2010; 58: 403-409.
600. 日本循環器学会心臓移植委員会．心臓移植の適応．［cited; Available from: http://plaza.umin.ac.jp/~hearttp/］
2167.
502. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic
patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008; 52: 1834-1843.
503. Mos s AJ , Hal l WJ , Cannom DS, et al . Cardiacresynchronization therapy for the prevention of heart-failure events. N Eng J Med 2009; 361: 1329-
1338.
504. Cleland JG, Freemantle N, Daubert JC, et al. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report
from the CARE-HF study. Heart (British Cardiac Society) 2008; 94: 278-283.
505. Curtis AB, Adamson PB, Chung E, et al. Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and
rationale. Journal of cardiovascular electrophysiology 2007; 18: 965-971.
506. Belardinelli R, Georgiou D, Cianci G, et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on
functional capacity, quality of life, and clinical outcome. Circulation 1999; 99: 1173-1182.
507. Stolen KQ, Kemppainen J, Ukkonen H, et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with
dilated cardiomyopathy. J Am Coll Cardiol 2003; 41: 460-467.
508. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation,
and autonomic function. Circulation 1992; 85: 2119-2131.
509. Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation,
and prevention. Circulation 2003; 107: 1210-1225.
510. Jette M, Heller R, Landry F, et al. Randomized 4-week exercise program in patients with impaired left ventricular function. Circulation 1991; 84: 1561-
1567.
511. Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll
Cardiol 1993; 21: 1101-1106.
512. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and
ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995; 25: 1239-1249.
513. Belardinelli R, Georgiou D, Scocco V, et al. Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol 1995; 26: 975-982.
514. Belardinelli R, Georgiou D, Cianci G, et al. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and
prognostic implications. Circulation 1995; 91: 2775-2784.
515. Kavanagh T, Myers MG, Baigrie RS, et al. Quality of life and cardiorespiratory function in chronic heart failure: effects of 12 months’ aerobic training.
Heart (British Cardiac Society) 1996; 76: 42-49.
516. Demopoulos L, Bijou R, Fergus I, et al. Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity while
minimizing the increase in ventricular wall stress. J Am Coll Cardiol 1997; 29: 597-603.
517. 安村良男，泰志 高洋原．β遮断薬服用中の慢性心不全患者に対する低レベル運動療法の試み．心臓リハビリテーション学会誌 1998.
518. Demopoulos L, Yeh M, Gentilucci M, et al. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in
patients with congestive heart failure. Circulation 1997; 95: 1764-1767.
519. Fitchet A, Doherty PJ, Bundy C, et al. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised
controlled trial. Heart (British Cardiac Society) 2003; 89: 155-160.
520. Kamke W, Dovifat C, Schranz M, et al. Cardiac rehabilitation in patients with implantable defibrillators. Feasibility and complications. Zeitschrift fur
Kardiologie 2003; 92: 869-875.
521. Belardinelli R, Capestro F, Misiani A, et al. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent
vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy. Eur J Cardiovasc Prev
Rehabil 2006; 13: 818-825.
522. Kruse M, Hochstrasser S, Zwisler AD, et al. Comprehensive cardiac rehabilitation: a cost assessment based on a randomized clinical trial. International
journal of technology assessment in health care 2006; 22: 478-483.
523. Haykowsky MJ, Liang Y, Pechter D, et al. A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the
benefit depends on the type of training performed. J Am Coll Cardiol 2007; 49: 2329-2336.
524. Giannuzzi P, Temporelli PL, Corra U, et al. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of
the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVDCHF) Trial. Circulation 2003; 108: 554-559.
525. Myers J, Wagner D, Schertler T, et al. Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy:
application of magnetic resonance myocardial tagging. Am Heart J 2002; 144: 719-725.
526. Passino C, Severino S, Poletti R, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart
failure. J Am Coll Cardiol 2006; 47: 1835-1839.
527. Maria Sarullo F, Gristina T, Brusca I, et al. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide
levels in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 812-817.
528. Wenger NK, Froelicher ES, Smith LK, et al. Cardiac rehabilitation as secondary prevention. Agency for Health Care Policy and Research and National
Heart, Lung, and Blood Institute. Clinical practice guideline 1995: 1-23.
529. Linxue L, Nohara R, Makita S, et al. Effect of long-term exercise training on regional myocardial perfusion changes in patients with coronary artery
disease. Jpn Circ J 1999; 63: 73-78.
530. Belardinelli R, Georgiou D, Ginzton L, et al. Effects of moderate exercise training on thallium uptake and contractile response to low-dose dobutamine of
dysfunctional myocardium in patients with ischemic cardiomyopathy. Circulation 1998; 97: 553-561.
531. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Eng J Med 2000; 342:
454-460.
532. Ohtsubo M, Yonezawa K, Nishijima H, et al. Metabolic abnormality of calf skeletal muscle is improved by localised muscle training without changes in blood
flow in chronic heart failure. Heart (British Cardiac Society) 1997; 78: 437-443.
533. Mancini DM, Henson D, La Manca J, et al. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic congestive heart
failure. Circulation. 1995; 91: 320-329.
534. Chua TP, Anker SD, Harrington D, et al. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. British
heart journal 1995; 74: 381-385.
535. Kobayashi N, Tsuruya Y, Iwasawa T, et al. Exercise training in patients with chronic heart failure improves endothelial function predominantly in the trained
extremities. Circ J 2003; 67: 505-510.
536. Hambrecht R, Adams V, Erbs S, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing
phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: 3152-3158.
537. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol
2005; 45: 1563-1569.
538. Adamopoulos S, Parissis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in
patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 653-663.
539. Oya M, Itoh H, Kato K, et al. Effects of exercise training on the recovery of the autonomic nervous system and exercise capacity after acute myocardial
infarction. Japanese Circulation journal 1999; 63: 843-848.
540. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, et al. Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart
failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 67-73.
541. Adamopoulos S, Ponikowski P, Cerquetani E, et al. Circadian pattern of heart rate variability in chronic heart failure patients. Effects of physical training.
Eur Heart J 1995; 16: 1380-1386.
542. Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. The American
journal of medicine 2004; 116: 693-706.
543. O’Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized
controlled trial. JAMA 2009; 301: 1439-1450.
544. Tei C. Waon therapy: soothing warmth therapy. J Cardiol 2007; 49: 301-304.
545. Tei C, Tanaka N. Thermal vasodilation as a treatment of congestive heart failure: a novel approach. J Cardiol 1996; 27: 29-30.
546. Basford JR, Oh JK, Allison TG, et al. Safety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: a pilot report.
Archives of physical medicine and rehabilitation 2009; 90: 173-177.
547. Kihara T, Biro S, Imamura M, et al. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure.
J Am Coll Cardiol 2002; 39: 754-759.
548. Kihara T, Biro S, Ikeda Y, et al. Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J 2004; 68:
1146-1151.
549. Kihara T, Miyata M, Fukudome T, et al. Waon therapy improves the prognosis of patients with chronic heart failure. J Cardiol 2009; 53: 214-218.
550. Ikeda Y, Biro S, Kamogawa Y, et al. Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in
cardiomyopathic hamsters. Circ J 2005; 69: 722-729.
551. 北村惣一郎，篤 天，真弘 遠，他．循環器病の診断と治療に関するガイドライン（2004－ 2005年度合同研究班報告）虚血性心疾患に対するバイパスグラフトと手
術術式の選択ガイドライン．Circ J 2006; 70 (Suppl. IV): 1477-1553.
552. Di Mauro M, Di Giammarco G, Vitolla G, et al. Impact of no-to-moderate mitral regurgitation on late results after isolated coronary artery bypass
grafting in patients with ischemic cardiomyopathy. The Annals of thoracic surgery 2006; 81: 2128-2134.
553. Filsoufi F, Rahmanian PB, Castillo JG, et al. Results and predictors of early and late outcome of coronary artery bypass grafting in patients with
severely depressed left ventricular function. The Annals of thoracic surgery 2007; 84: 808-816.
554. Dor V, Sabatier M, Di Donato M, et al. Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular
dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 1998; 116: 50-59.
555. Suma H, Isomura T, Horii T, et al. Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. The Annals of thoracic
surgery 2006; 82: 1344-1348.
556. Menicanti L, Castelvecchio S, Ranucci M, et al. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular
restoration. J Thorac Cardiovasc Surg 2007; 134: 433-441.
557. Matsui Y, Fukada Y, Suto Y, et al. Overlapping cardiac volume reduction operation. J Thorac Cardiovasc Surg 2002; 124: 395-397.
558. Jones RH, Velazquez EJ, Michler RE, et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Eng J Med 2009; 360:
1705-1717.
559. Buckberg GD. Questions and answers about the STICH trial a different perspective. J Thorac Cardiovasc Surg 2005; 130: 245-249.
560. Batista RJ, Santos JL, Takeshita N, et al. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. Journal of cardiac
surgery 1996; 11: 96-97; discussion 8.
561. Franco-Cereceda A, McCarthy PM, Blackstone EH, et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to
transplantation? J Thorac Cardiovasc Surg 2001; 121: 879-893.
562. Suma H, Isomura T, Horii T, et al. Nontransplant cardiac surgery for end-stage cardiomyopathy. J Thorac Cardiovasc Surg 2000; 119: 1233-1244.
563. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults:
a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration
with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
564. Suma H, Tanabe H, Uejima T, et al. Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy. Eur
J Cardiothorac Surg. 2009; 36: 280-284; discussion 4-5.
565. Bolling SF, Pagani FD, Deeb GM, et al. Intermediate-term Cardiovasc Surg 1998; 115: 381-386; discussion 7-8.
566. Daimon M, Fukuda S, Adams DH, et al. Mitral valve repair with Carpentier-McCarthy-Adams IMR ETlogix annuloplasty ring for ischemic mitral
regurgitation: early echocardiographic results from a multi-center study. Circulation 2006; 114 (1 Suppl.): I588-593.
567. Calafiore AM, Di Mauro M, Gallina S, et al. Mitral valve surgery for chronic ischemic mitral regurgitation. The Annals of thoracic surgery 2004; 77:
1989-1997.
568. Borger MA, Murphy PM, Alam A, et al. Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J Thorac Cardiovasc Surg 2007;
133: 1483-1492.
569. Matsui Y, Fukada Y, Naito Y, et al. Integrated overlapping ventriculoplasty combined with papillary muscle plication for severely dilated heart failure.
J Thorac Cardiovasc Surg 2004; 127: 1221-1223.
570. Kron IL, Green GR, Cope JT. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. The Annals of thoracic
surgery 2002; 74: 600-601.
571. Langer F, Schafers HJ. RING plus STRING: papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation. J Thorac
Cardiovasc Surg 2007; 133: 247-249.
572. 松田暉，大北裕，川副浩平，他．循環器病の診断と治療に関するガイドライン（2006年度合同研究班報告）：弁膜疾患の非薬物治療に関するガイドライン
（2007年改訂版）．2007.
573. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the
American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for
the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists:
endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-231.
574. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left
ventricular dysfunction. J Am Coll Cardiol 2002; 39: 1356-1363.
575. Taniguchi K, Nakano S, Hirose H, et al. Preoperative left ventricular function: minimal requirement for successful late results of valve replacement for
aortic regurgitation. J Am Coll Cardiol 1987; 10: 510-518.
576. Horskotte D, Schulte HD, Bircks W, et al. The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study. The
Journal of heart valve disease. 1993; 2: 150-158.
577. Bonow RO, Nikas D, Elefteriades JA. Valve replacement for regurgitant lesions of the aortic or mitral valve in advanced left ventricular dysfunction.
Cardiology clinics 1995; 13: 73-83, 5.
578. Ling LH, Oh JK, Schaff HV, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy.
Circulation 1999; 100: 1380-1386.
579. Maisch B, Seferovic PM, Ristic AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on
the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004; 25: 587-610.
580. Ha JW, Oh JK, Schaff HV, et al. Impact of left ventricular function on immediate and long-term outcomes after pericardiectomy in constrictive
pericarditis. J Thorac Cardiovasc Surg 2008; 136: 1136-1141.
581. Schwefer M, Aschenbach R, Heidemann J, et al. Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management. Eur
J Cardiothorac Surg 2009; 36: 502-510.
582. Ueda Y, Osada H, Osugi H. Thoracic and cardiovascular surgery in Japan during 2005. Annual report by the Japanese Association for Thoracic Surgery.
General thoracic and cardiovascular surgery 2007; 55: 377-399.
583. Ueda Y, Fujii Y, Udagawa H. Thoracic and cardiovascular surgery in Japan during 2006: annual report by the Japanese Association for Thoracic Surgery.
General thoracic and cardiovascular surgery 2008; 56: 365-388.
584. 三瀬直文，杉本徳一郎．持続的血液濾過透析．日本臨床2007; 915: 259-262.
585. 馬場彰泰，村山章，若林靖久．拡張型心筋症患者の免疫吸着療法に有効な吸着カラムの同定．日本アフェレシス学会雑誌 2004; 23: 101-102.
586. Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced
myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999; 33: 1833-1840.
587. 中谷武嗣．新版経皮的心肺補助法－PCPSの最前線．秀潤社 2004: 141-148.
588. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device
versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588.
589. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk
percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. Jacc 2009; 2: 91-96.
590. Yahagi N, Kumon K, Nakatani T, et al. Inhaled nitric oxide for the management of acute right ventricular failure in patients with a left ventricular assist
system. Artificial organs 1995; 19: 557-578.
591. Takano H, Nakatani T. Ventricular assist systems: experience in Japan with Toyobo pump and Zeon pump. The Annals of thoracic surgery 1996; 61:
317-322.
592. 中谷武嗣．補助人工心臓 日本内科学会雑誌．2005: 111-118.
593. Frazier OH, Rose EA, Macmanus Q, et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. The Annals of thoracic
surgery 1992; 53: 1080-1090.
594. Kormos RL, Murali S, Dew MA, et al. Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. The Annals of
thoracic surgery 1994; 57: 51-57; discussion 7-8.
595. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left
ventricular assist system. Annals of surgery 1995; 222: 327-336; discussion 36-38.
596. Hetzer R, Muller J, Weng Y, et al. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. The Annals of thoracic
surgery 1999; 68: 742-749.
597. Copeland JG, Pavie A, Duveau D, et al. Bridge to transplantation with the CardioWest total artificial heart: the international experience 1993 to 1995.
J Heart Lung Transplant 1996; 15 (1 Pt 1): 94-99.
598. Dowling RD, Gray LA, Jr., Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004;
127: 131-141.
599. 許俊鋭．本邦におけるDestination Therapyの夜明け．呼吸と循環 2010; 58: 403-409.
600. 日本循環器学会心臓移植委員会．心臓移植の適応．［cited; Available from: http://plaza.umin.ac.jp/~hearttp/］
文献
慢性心不全治療ガイドライン（2010年改訂版）
Guidelines for Treatment of Chronic Heart Failure（JCS 2010）
Guidelines for Treatment of Chronic Heart Failure（JCS 2010）